| 1CQP | A:; B: | CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION |
| 1DGQ | A: | NMR SOLUTION STRUCTURE OF THE INSERTED DOMAIN OF HUMAN LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1 |
| 1LFA | A:; B: | CD11A I-DOMAIN WITH BOUND MN++ |
| 1MJN | A: | CRYSTAL STRUCTURE OF THE INTERMEDIATE AFFINITY AL I DOMAIN MUTANT |
| 1MQ8 | B:; D: | CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1 |
| 1MQ9 | A: | CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN WITH LIGAND MIMETIC CRYSTAL CONTACT |
| 1MQA | A: | CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN IN THE ABSENCE OF LIGAND OR METAL |
| 1RD4 | A:; B:; C:; D: | AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN |
| 1T0P | A: | STRUCTURAL BASIS OF ICAM RECOGNITION BY INTEGRIN ALPAHLBETA2 REVEALED IN THE COMPLEX STRUCTURE OF BINDING DOMAINS OF ICAM-3 AND ALPHALBETA2 AT 1.65 A |
| 1XDD | A:; B: | X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION |
| 1XDG | A:; B: | X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION |
| 1XUO | A:; B: | X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 1,4-DIAZEPANE-2,5-DIONE INHIBITOR AT 1.8A RESOLUTION |
| 1ZON | A: | CD11A I-DOMAIN WITHOUT BOUND CATION |
| 1ZOO | A:; B: | CD11A I-DOMAIN WITH BOUND MAGNESIUM ION |
| 1ZOP | A:; B: | CD11A I-DOMAIN WITH BOUND MAGNESIUM ION |
| 2ICA | A: | CD11A (LFA1) I-DOMAIN COMPLEXED WITH BMS-587101 AKA 5-[(5S, 9R)-9-(4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1-METHYL-2,4-DIOXO-1,3,7-TRIAZASPIRO [4.4]NON-7-YL]METHYL]-3-THIOPHENECARBOXYLICACID |
| 2O7N | A: | CD11A (LFA1) I-DOMAIN COMPLEXED WITH 7A-[(4-CYANOPHENYL) METHYL]-6-(3,5-DICHLOROPHENYL)-5-OXO-2,3,5,7A-TETRAHYDRO-1H-PYRROLO[1,2-A]PYRROLE-7-CARBONITRILE |
| 3BN3 | A: | CRYSTAL STRUCTURE OF ICAM-5 IN COMPLEX WITH AL I DOMAIN |
| 3BQM | B:; C: | LFA-1 I DOMAIN BOUND TO INHIBITORS |
| 3BQN | B:; C: | LFA-1 I DOMAIN BOUND TO INHIBITORS |
| 3E2M | A:; B: | LFA-1 I DOMAIN BOUND TO INHIBITORS |
| 3EOA | I:; J: | CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN, FORM I |
| 3F74 | A:; B:; C: | CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN |
| 3F78 | A:; B:; C: | CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE |
| 3M6F | A: | CD11A I-DOMAIN COMPLEXED WITH 6-((5S,9R)-9-(4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1-METHYL-2,4-DIOXO-1,3,7- TRIAZASPIRO[4.4]NON-7-YL) NICOTINIC ACID |
| 4IXD | A: | X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH IBE-667 AT 1.8A RESOLUTION |
)
)